GLP-1赛道硝烟四起,“双子星”大战,国内企业卷出“新花样”。图片来源:图虫创意诺和诺德和礼来制药的渠道争夺战战火烧至线上。12月23日,时代财经检索线上购药平台发现,礼来的明星减重/降糖药物替尔泊肽(商品:穆峰达)已有可预约界面,相关信息显示,“同意并预约后,将在到货后通知有意愿的购买者。”当日晚间,替尔泊肽在美团限时首发开售。接近美团人士向时代财经透露,首发当晚3秒售罄,预约量日环比超三倍,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.